Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin- converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 74, Issue 2, 1997, Pages 207-212

  Tysoe, Carolyn ^a   Galinsky, Daliah ^a   Robinson, Damian ^b   Brayne, Carol E ^b   Easton, Douglas F ^b   Huppert, Felicia A ^c   Dening, Tom ^c   Paykel, Eugene S ^c   Rubinsztein, David C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

alpha 1 antichymotrypsin; Alzheimer disease; dementia; presenilin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E4; DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ALLELE; ARTICLE; DEMENTIA; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; COHORT STUDIES; DEMENTIA; GENOTYPE; HUMANS; MEMBRANE PROTEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PEPTIDYL-DIPEPTIDASE A; PRESENILIN-1;

EID: 0030942430     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19970418)74:2<207::AID-AJMG20>3.0.CO;2-L     Document Type: Article

References (29)

1. American Psychiatric Association. (1987) "Diagnostic and Statistical Manual of Mental Disorders. Third Edition, Revised." Washington, DC: American Psychiatric Association, p 107.
2. Bell IR, Edman JS, Selhub J, Morrow FD, Marby DW, Kayne HL, Cole JO (1992): Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 86:386-390.
3. Beohar N, Damaraju S, Prather A, Yu QT, Raizner A, Kleiman NS, Roberts R, Marian AJ (1995): Angiotensin-1 converting enzyme genotype DD is a risk factor for CAD. J Invest Med 43:275-280.
4. Breslow NE Day NE (1987): "Analysis and Design of Cohort Studies," Volume 2. Lyon: IARC Publications, pp. 291-293.
5. Chadwick C (1992): The MRC multicentre study of cognitive function and aging: A EURODEM incidence study in progress. Neuroepidemiology [Suppl] 1:37-43.
6. Chartier-Harlin M-C, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V, Fruchart J-C, Delacourte A, Rossor M, Amouyel P (1994): Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3:569-574.
7. Copeland JRM, Kelleher MJ, Kellet JM, Gourlay AJ (1976): A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: The Geriatric Mental State Schedule. Psychol Med 6:439-449.
8. Copeland JRM, Dewey ME, Griffiths-Jones HM (1986): A computerized psychiatric diagnostic system and case nomenclature for elderly subjects - GMS and AGECAT. Psychol Med 16:89-99.
9. Folstein MF, Folstein SE, McHugh PR (1975): "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R (1995): A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
11. Haines JL, Pritchard ML, Saunders AM, Schildraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance MA (1996): No genetic effect of α1-antichymotrypsin in Alzheimer disease. Genomics 33:53-56.
12. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb, PA (1995): Apolipoprotein-E allele epsilon-4, dementia and cognitive decline in a population sample. Lancet 346:1387-1390.
13. Heston LL (1992): Alzheimer's disease. In King, RA, Rotter JI, Motulsky AG (eds): "The Genetic Basis of Common Diseases." Oxford: Oxford University Press.
14. Higuchi S, Muramatsu T, Matsushita S, Arai H, Sasaki H (1996): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1186.
15. Hixson JE, Vernier DT (1990): Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 31:545-548.
16. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB (1995): Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study. Neurology 45:1092-1096.
17. Jarvik GP, Larson EB, Goddard K, Kukull WA, Schellenberg GD, Wijsman EM (1996): Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 58:191-200.
18. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995): ApoE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet 10:486-488.
19. Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ, UK Alzheimer's Disease Collaborative Group (1996): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1185.
20. Paykel ES, Brayne C, Huppert FA, Gill C, Barkley C, Gelhaar E, Beardsall L, Girling D, Pollitt P, O'Connor D (1994): Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 51:325-332.
21. Perez-Tur J, Wavrant-De Vrieze F, Lambert JC, Chartier Harlin M-C, Alzheimer's Study Group (1996): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1561.
22. Rigat B, Hubert C, Corvol P, Soubrier F (1992): PCR detection of the insertion deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase). Nucleic Acids Res 20:1433.
23. Roth M, Tym E, Mountjoy CQ, Huppert F, Hendrie H, Verma S, Doddard R (1986): CAMDEX - A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698-709.
24. Roth M, Huppert FA, Tym E, Mountjoy CQ (1988): "CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly." Cambridge: Cambridge University Press.
25. Rubinsztein DC (1995): Apolipoprotein E: A review of its role in lipoprotein metabolism, neuronal growth and as a risk factor for Alzheimer's disease. Psychol Med 25:223-229.
26. Sandbrink R, Hartmann T, Masters CL, Beyreuther K (1996): Genes contributing to Alzheimer's disease. Mol Psychiatry 1:27-40.
27. Scott WK, Growdon JH, Roses AD, Haines JL, Pericak Vance MA (1996): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1186-1187.
28. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Oden A, Svanborg A (1996): 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145.
29. Wragg M, Hutton M, Talbot, Alzheimer's Disease Collaborative Group (1996): Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347:509-512.